Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

被引:0
|
作者
Akiko Ogiya
Kieko Yamazaki
Rie Horii
Tadahiko Shien
Yoshiya Horimoto
Norikazu Masuda
Touko Inao
Mitsuchika Hosoda
Naoko Ishida
Tomofumi Osako
Masato Takahashi
Yumi Endo
Yuichiro Miyoshi
Hiroyuki Yasojima
Nobumoto Tomioka
Hiroko Yamashita
机构
[1] Japanese Foundation for Cancer Research,Breast Surgical Oncology, Cancer Institute Hospital
[2] Cancer Institute of the Japanese Foundation for Cancer Research,Division of Pathology
[3] Okayama University Hospital,Breast and Endocrine Surgery
[4] Juntendo University School of Medicine,Department of Breast Oncology
[5] NHO Osaka National Hospital,Department of Surgery, Breast Oncology
[6] Graduate School of Medical Science Kumamoto University,Department of Breast and Endocrine Surgery
[7] Hokkaido University Hospital,Breast Surgery
[8] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[9] Kumamoto Shinto General Hospital,Department of Breast Surgery
[10] NHO Hokkaido Cancer Center,Department of Oncology, Immunology and Surgery
[11] Nagoya City University Graduate School of Medical Sciences,undefined
来源
Breast Cancer | 2017年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:642 / 642
相关论文
共 50 条
  • [31] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Hao, Shuang
    Shao, Zhi-Ming
    BMC MEDICINE, 2015, 13
  • [32] Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
    Cantini, Luca
    Trapani, Dario
    Guidi, Lorenzo
    Bielo, Luca Boscolo
    Scafetta, Roberta
    Koziej, Marcin
    Vidal, Laura
    Saini, Kamal S.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2024, 123
  • [33] Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
    Ke-Da Yu
    Yi-Zhou Jiang
    Shuang Hao
    Zhi-Ming Shao
    BMC Medicine, 13
  • [34] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Jin, Xi
    Zhou, Yi-Fan
    Ma, Ding
    Zhao, Shen
    Lin, Cai-Jin
    Xiao, Yi
    Fu, Tong
    Liu, Cheng-Lin
    Chen, Yi-Yu
    Xiao, Wen-Xuan
    Liu, Ya-Qing
    Chen, Qing-Wang
    Yu, Ying
    Shi, Le-Ming
    Shi, Jin-Xiu
    Huang, Wei
    Robertson, John F. R.
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    NATURE GENETICS, 2023, 55 (10) : 1696 - +
  • [35] Neoadjuvant Therapy for weak receptor-positive/HER2-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1124 - 1124
  • [36] Molecular classification of hormone receptor-positive HER2-negative breast cancer
    Xi Jin
    Yi-Fan Zhou
    Ding Ma
    Shen Zhao
    Cai-Jin Lin
    Yi Xiao
    Tong Fu
    Cheng-Lin Liu
    Yi-Yu Chen
    Wen-Xuan Xiao
    Ya-Qing Liu
    Qing-Wang Chen
    Ying Yu
    Le-Ming Shi
    Jin-Xiu Shi
    Wei Huang
    John F. R. Robertson
    Yi-Zhou Jiang
    Zhi-Ming Shao
    Nature Genetics, 2023, 55 : 1696 - 1708
  • [37] Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
    Zhang, Yi
    Schnabel, Catherine A.
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Jankowitz, Rachel C.
    Fornander, Tommy
    Stal, Olle
    Brufsky, Adam M.
    Sgroi, Dennis
    Erlander, Mark G.
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4196 - 4205
  • [38] Clinical considerations for estrogen receptor-negative/ progesterone receptor-positive/HER2-negative (ER-PR+HER2-) breast cancer
    Rala de Paula, Bruno Henrique
    Crocamo, Susanne
    Bines, Jose
    TRANSLATIONAL BREAST CANCER RESEARCH, 2023, 4
  • [39] Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer
    Dowsett, Mitch
    Sestak, Ivana
    Buus, Richard
    Lopez-Knowles, Elena
    Mallon, Elizabeth
    Howell, Anthony
    Forbes, John F.
    Buzdar, Aman
    Cuzick, Jack
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2763 - 2770
  • [40] Lymph Node Metastasis Is Not Predictive of Overall Survival, Disease Free Survival, or Metastasis in Estrogen Receptor-Positive/Her2-Negative Breast Cancer
    Logan, Suzanna J.
    Sonmez, Ceyda
    Zhang, Chao
    Neely, Cameron
    Mendoza, Pia
    Arciero, Cletus
    Liu, Yuan
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2017, 97 : 57A - 57A